Inclinix and JSW Life Sciences form strategic partnership
Thursday, February 23, 2012
Inclinix, which specializes in customized phase I-IV clinical enrollment solutions, has selected CRO JSW Life Sciences as its European partner to support enrollment of its clinical trials throughout Europe.
The strategic partnership places Inclinix offices in Graz, Austria, and expands Inclinix by more than 100 enrollment professionals in Eastern and Western Europe.
“As Inclinix has experienced significant growth over the past year, it has been important for us to identify a European partner that shares our philosophy and performance enrollment model,” said J. Tobin Geatz, Inclinix president and CEO.
The Inclinix Clinical Enrollment Manager (CEM) programs offer a unique approach to global clinical trial enrollment. CEMs provide in-field enrollment support to investigative sites, focusing on identifying qualified study candidates not only from within the sites’ practices, but also from the surrounding medical and patient communities.
“We are excited to combine our clinical expertise and native-language teams with Inclinix’s enrollment experience. We look forward to many successful enrollment campaigns through this partnership,” said Dr. Manfred Windisch, CEO of JSW Life Sciences.